{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:17:47Z","timestamp":1790893067987,"version":"4.1.0"},"reference-count":100,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 103-2923-B-037-001-MY2"],"award-info":[{"award-number":["MOST 103-2923-B-037-001-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kaohsiung City Government","award":["T105004"],"award-info":[{"award-number":["T105004"]}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jfda.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T13:46:17Z","timestamp":1492523177000},"page":"461-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["New psychoactive substances of natural origin: A\u00a0brief review"],"prefix":"10.38212","volume":"25","author":[{"given":"Ling-Yi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altansuvd","family":"Battulga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2017.04.001_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/scientificamerican0791-40","article-title":"Opium, cocaine and marijuana in American history","volume":"265","author":"Musto","year":"1991","journal-title":"Sci Am"},{"key":"10.1016\/j.jfda.2017.04.001_bib2","series-title":"Single convention on narcotic drugs","year":"1961"},{"key":"10.1016\/j.jfda.2017.04.001_bib3","series-title":"Convention on psychotropic substances","year":"1971"},{"key":"10.1016\/j.jfda.2017.04.001_bib4","series-title":"Convention against illicit. Traffic in narcotic drugs and psychotropic substances","year":"1988"},{"key":"10.1016\/j.jfda.2017.04.001_bib5","series-title":"Global synthetics monitoring: analyses, reporting and trends (SMART) programme","author":"The challenge of new psychoactive substances","year":"2013"},{"key":"10.1016\/j.jfda.2017.04.001_bib6","unstructured":"UNODC early warning advisory (EWA) on new psychoactive substances (NPS). United Nations Office on Drugs and Crime. Available at: https:\/\/www.unodc.org\/LSS\/Home\/NPS."},{"key":"10.1016\/j.jfda.2017.04.001_bib7","first-page":"5","article-title":"The chemistry of khat","volume":"32","author":"Szendrei","year":"1980","journal-title":"Bull Narc"},{"key":"10.1016\/j.jfda.2017.04.001_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.phytol.2015.05.016","article-title":"The psychostimulant drug khat (Catha edulis): a mini-review","volume":"13","author":"Nichols","year":"2015","journal-title":"Phytochem Lett"},{"key":"10.1016\/j.jfda.2017.04.001_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09603120701254813","article-title":"High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background","volume":"17","author":"Sawair","year":"2007","journal-title":"Int J Env Health Res"},{"key":"10.1016\/j.jfda.2017.04.001_bib10","unstructured":"Khat drug profile. European monitoring centre for drugs and drug addiction. Available at: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/khat."},{"key":"10.1016\/j.jfda.2017.04.001_bib11","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1016\/j.orcp.2010.07.001","article-title":"Direct effect of khat and garlic extracts on blood lipids contents: preliminary in\u00a0vitro study","volume":"4","author":"Aziz","year":"2010","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.jfda.2017.04.001_bib12","first-page":"137","article-title":"Chemistry, pharmacology, and toxicology of khat (catha edulis forsk): a review","volume":"3","author":"Nasir Tajure","year":"2011","journal-title":"Addict Health"},{"key":"10.1016\/j.jfda.2017.04.001_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1192\/apt.9.6.456","article-title":"Adverse effects of khat: a review","volume":"9","author":"Glenice","year":"2003","journal-title":"Adv Psychiatr Treat"},{"key":"10.1016\/j.jfda.2017.04.001_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0376-8716(89)90029-X","article-title":"Khat consumption - a pharmacological review","volume":"23","author":"Nencini","year":"1989","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jfda.2017.04.001_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0031-6997(25)06823-1","article-title":"Pharmacological aspects of the chewing of khat leaves","volume":"37","author":"Kalix","year":"1985","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jfda.2017.04.001_bib16","first-page":"69","article-title":"Flower of paradise (khat: catha edulis): psychosocial, health and sports perspect","volume":"24","author":"Sikiru","year":"2012","journal-title":"Afr J Health Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jep.2007.08.042","article-title":"Developmental patterns of phenylpropylamino alkaloids accumulation in khat (Catha edulis, Forsk.)","volume":"114","author":"Krizevski","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14740338.4.6.1145","article-title":"The potential adverse effects of habitual use of Catha edulis (khat)","volume":"4","author":"Molham","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jfda.2017.04.001_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0163-7258(90)90057-9","article-title":"Pharmacological properties of the stimulant khat","volume":"48","author":"Kalix","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jfda.2017.04.001_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.pnpbp.2007.12.033","article-title":"A review of the neuropharmacological properties of khat","volume":"32","author":"Feyissa","year":"2008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jfda.2017.04.001_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jep.2010.07.001","article-title":"Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research","volume":"132","author":"Al-Motarreb","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","article-title":"In\u00a0vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates","volume":"307","author":"Rothman","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2017.04.001_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2013.11.032","article-title":"Cathinone increases body temperature, enhances locomotor activity, and induces striatal c-fos expression in the Siberian hamster","volume":"559","author":"Jones","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfda.2017.04.001_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in\u00a0vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jep.2013.02.011","article-title":"Khat dependence syndrome: a crosssectional preliminary evaluation amongst UK-resident Yemeni khat chewers","volume":"146","author":"Kassim","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00702-005-0356-7","article-title":"Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats","volume":"113","author":"Banjaw","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jfda.2017.04.001_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5507\/bp.2004.002","article-title":"Khat habit and its health effect. A natural amphetamine","volume":"148","author":"Ishraq","year":"2004","journal-title":"Biomed Pap"},{"key":"10.1016\/j.jfda.2017.04.001_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: a review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jfda.2017.04.001_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jep.2010.05.033","article-title":"Khat use and neurobehavioral functions: suggestions for future studies","volume":"132","author":"Hoffman","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/156802611795371305","article-title":"Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity","volume":"11","author":"Adkins","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jfda.2017.04.001_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.jfda.2017.04.001_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-8741(88)90121-3","article-title":"Ethnopharmacology of kratom and the mitragyma alkaloids","volume":"23","author":"Jansen","year":"1988","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.aap.2009.01.010","article-title":"Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey","volume":"41","author":"Ingsathit","year":"2009","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.jfda.2017.04.001_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11418-009-0325-9","article-title":"The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets","volume":"63","author":"Maruyama","year":"2009","journal-title":"J Nat Med"},{"key":"10.1016\/j.jfda.2017.04.001_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/15563650701241795","article-title":"Opioid receptors and legal highs: salvia divinorum and Kratom","volume":"46","author":"Babu","year":"2008","journal-title":"Clin Tox"},{"key":"10.1016\/j.jfda.2017.04.001_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","article-title":"The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy","volume":"21","author":"Vicknasingam","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jfda.2017.04.001_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2006.08.013","article-title":"Involvement of muopioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","volume":"549","author":"Matsumoto","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib38","unstructured":"Kratom (Mitragyna speciosa) drug profile. European Monitoring Centre for Drugs and Drug Addiction. Available at: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/kratom."},{"key":"10.1016\/j.jfda.2017.04.001_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jep.2010.03.035","article-title":"The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.)","volume":"129","author":"Chittrakarn","year":"2010","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib40","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Walter","year":"2012","journal-title":"J Am Osteopath Asso"},{"key":"10.1016\/j.jfda.2017.04.001_bib41","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","article-title":"Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands","volume":"45","author":"Takayama","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.jfda.2017.04.001_bib42","series-title":"Micro bull \u2013 heroin-fentanyl mixtures in Cleveland, Ohio","author":"Administration USDoJDE","year":"2006"},{"key":"10.1016\/j.jfda.2017.04.001_bib43","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0040-4039(01)90746-4","article-title":"Mitragyna alkaloids: the structure of stipulatine","volume":"4","author":"James","year":"1963","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.jfda.2017.04.001_bib44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/11596830-000000000-00000","article-title":"Herbal medicines for the management of opioid addiction safe and effective alternatives to conventional pharmacotherapy?","volume":"25","author":"Ward","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jfda.2017.04.001_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11419-009-0070-5","article-title":"Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant \u201ckratom\u201d (Mitragyna speciosa) by LC-ESI-MS","volume":"27","author":"Kikura-Hanajiri","year":"2009","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.jfda.2017.04.001_bib46","first-page":"21","article-title":"A study of kratom eaters in Thailand","volume":"27","author":"Sangun","year":"1975","journal-title":"Bull Narc"},{"key":"10.1016\/j.jfda.2017.04.001_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2006-960132","article-title":"Ursolic acid from mitragyna-speciosa","volume":"57","author":"Said","year":"1991","journal-title":"Planta Med"},{"key":"10.1016\/j.jfda.2017.04.001_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0024-3205(97)00023-4","article-title":"Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated Guinea-pig ileum through the opioid receptor","volume":"60","author":"Watanabe","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib49","series-title":"A dictionary of the economic products of the malay Peninsula: governments of the straits settlements and federated malay states by the crown agents for the colonies","author":"Burkill","year":"2009"},{"key":"10.1016\/j.jfda.2017.04.001_bib50","first-page":"145","article-title":"Some observations on the pharmacology of mitragynine","volume":"198","author":"Macko","year":"1972","journal-title":"Arch Int Pharmacodyn Th\u00e9r"},{"key":"10.1016\/j.jfda.2017.04.001_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2004.10.086","article-title":"Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa","volume":"78","author":"Matsumoto","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-013-3201-y","article-title":"Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract","volume":"231","author":"Stolt","year":"2014","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jfda.2017.04.001_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/phar.1522","article-title":"New drugs of abuse","volume":"35","author":"Megan","year":"2015","journal-title":"Pharmacother"},{"key":"10.1016\/j.jfda.2017.04.001_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2005.04.042","article-title":"Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens","volume":"78","author":"Matsumoto","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib56","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0024-3205(98)00075-7","article-title":"Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","volume":"62","author":"Thongpradichote","year":"1998","journal-title":"Life S. C"},{"key":"10.1016\/j.jfda.2017.04.001_bib57","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1248\/cpb.52.916","article-title":"Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa","volume":"52","author":"Takayama","year":"2004","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.jfda.2017.04.001_bib58","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1080\/10826080701205869","article-title":"The use of Mitragynine speciosa (\u201cKrathom\u201d), an addictive plant, in Thailand","volume":"42","author":"Assanangkornchai","year":"2007","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.jfda.2017.04.001_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-8741(89)90053-6","article-title":"Ethnopharmacology of kratom and the mitragyna alkaloids","volume":"25","author":"Shellard","year":"1989","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(25)07997-2","article-title":"Observations on the pharmacology of mitragynine","volume":"46","author":"Grewal","year":"1932","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2017.04.001_bib61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/anatox\/35.4.242","article-title":"Unintentional fatal intoxications with mitragynine and O-Desmethyltramadol from the herbal blend krypton","volume":"35","author":"Kronstrand","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jfda.2017.04.001_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.forsciint.2010.10.025","article-title":"Kratom alkaloids and O-desmethyltramadol in urine of a \u201cKrypton\u201d herbal mixture consumer","volume":"208","author":"Arndt","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jfda.2017.04.001_bib63","article-title":"Following \u201cthe roots\u201d of kratom (mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in western countries","volume":"11","author":"Cinosi","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jfda.2017.04.001_bib64","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1345\/aph.1G185","article-title":"Evaluation of herbal dietary supplements marketed on the internet for recreational use","volume":"39","author":"Dennehy","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jfda.2017.04.001_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.lfs.2005.09.008","article-title":"Psychopharmacology of the hallucinogenic sage Salvia divinorum","volume":"78","author":"Prisinzano","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1542\/peds.2004-1199","article-title":"The Internet and psychoactive substance use among innovative drug users","volume":"115","author":"Boyer","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfda.2017.04.001_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.110.003244","article-title":"Neuropharmacology of the naturally occurring \u03ba-opioid hallucinogen Salvinorin A","volume":"63","author":"Christopher","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jfda.2017.04.001_bib68","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2009.06.044","article-title":"Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence","volume":"57","author":"Hooker","year":"2009","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FBP.0b013e328349fc1b","article-title":"Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A","volume":"22","author":"Peet","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib70","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3762\/bjoc.9.328","article-title":"Studies toward bivalent \u03ba opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity","volume":"9","author":"Munro","year":"2013","journal-title":"Beilstein J Org Chem"},{"key":"10.1016\/j.jfda.2017.04.001_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2011.10.026","article-title":"Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology","volume":"121","author":"Lamb","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jfda.2017.04.001_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pbb.2005.12.011","article-title":"Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist","volume":"83","author":"McCurdy","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jfda.2017.04.001_bib73","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1021\/jm048963m","article-title":"Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands","volume":"48","author":"Harding","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.jfda.2017.04.001_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2982.2005.00725.x","article-title":"The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the Guinea-pig ileum","volume":"18","author":"Capasso","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jfda.2017.04.001_bib75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00008877-200512000-00005","article-title":"Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse","volume":"16","author":"Fantegrossi","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib76","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jfda.2017.04.001_bib77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2017.04.001_bib78","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.jfda.2017.04.001_bib79","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00004714-200112000-00025","article-title":"Antidepressant effects of the herb salvia divinorum: a case report","volume":"21","author":"Hanes","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-8741(94)90116-3","article-title":"Salvia divinorum and salvinorin A: new pharmacologic findings","volume":"43","author":"Daniel","year":"1994","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib81","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20191","article-title":"Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin a in nonhuman primates","volume":"58","author":"Schmidt","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.jfda.2017.04.001_bib82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02791072.2003.10400021","article-title":"Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin a","volume":"35","author":"Mowry","year":"2003","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.jfda.2017.04.001_bib83","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1592\/phco.26.9.1268","article-title":"Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products","volume":"26","author":"Wolowich","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jfda.2017.04.001_bib84","unstructured":"Hallucinogenic mushrooms drug profile. European monitoring centre for drugs and drug addiction. Available at: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/mushrooms."},{"key":"10.1016\/j.jfda.2017.04.001_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jat\/22.1.45","article-title":"Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions","volume":"22","author":"Beck","year":"1998","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jfda.2017.04.001_bib86","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jfda.2017.04.001_bib87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269881106065859","article-title":"Effects of psilocybin on time perception and temporal control of behaviour in humans","volume":"21","author":"Wittmann","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050860","article-title":"Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - results of an experimental double blind placebo controlled study","volume":"142","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jfda.2017.04.001_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yrtph.2011.01.006","article-title":"Harm potential of magic mushroom use: a review","volume":"59","author":"van Amsterdam","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jfda.2017.04.001_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/10826080701772363","article-title":"Between prohibitions: patterns and meanings of magic mushroom use in the UK","volume":"43","author":"Riley","year":"2008","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jfda.2017.04.001_bib91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14659890903271624","article-title":"User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study","volume":"15","author":"Carhart-Harris","year":"2010","journal-title":"J Subst Use"},{"key":"10.1016\/j.jfda.2017.04.001_bib92","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.phytochem.2005.07.016","article-title":"Substances isolated from Mandragora species","volume":"66","author":"Hanus","year":"2005","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jfda.2017.04.001_bib93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/15563658208992510","article-title":"A case of mandrake poisoning","volume":"19","author":"Vlachos","year":"1982","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.jfda.2017.04.001_bib94","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1001\/archinte.1997.00440380117012","article-title":"Mandrake toxicity. A case of mistaken identity","volume":"157","author":"Frasca","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfda.2017.04.001_bib95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0531-5131(02)00699-4","article-title":"Pain relief and sedation in roman byzantine texts: mandragoras officinarum, hyoscyamos Niger and atropa belladonna","volume":"1242","author":"Ramoutsaki","year":"2002","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.jfda.2017.04.001_bib96","series-title":"The history of anaesthesia london: the royal society of medicine services and the parthenon publishing group","first-page":"38","article-title":"Anaesthesia with mandrake in the tradition of Dioscorides and its role in classical antiquity","author":"Hintzenstern","year":"1989"},{"key":"10.1016\/j.jfda.2017.04.001_bib97","series-title":"Mandrake in the history of anaesthesia","first-page":"26","author":"Bowes","year":"1989"},{"key":"10.1016\/j.jfda.2017.04.001_bib98","series-title":"The oxford companion to the body","author":"Blakemore","year":"2003"},{"key":"10.1016\/j.jfda.2017.04.001_bib99","first-page":"486","article-title":"Analgesia and anesthesia: etymology and literary history of related Greek words","volume":"91","author":"Askitopoulou","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jfda.2017.04.001_bib100","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: the science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J Neurosci"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949817300844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949817300844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949817300844?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:51:51Z","timestamp":1750200711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949817300844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1021949817300844"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2017.04.001","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New psychoactive substances of natural origin: A\u00a0brief review","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}